Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry

BACKGROUND: Familial hypercholesterolemia (FH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease (CVD) risk. FH patients often have increased lipoprotein(a) [Lp(a)] levels, which further increase CVD risk. Novel methods for accuratel...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizos, Christos V., Florentin, Matilda, Skoumas, Ioannis, Tziomalos, Konstantinos, Rallidis, Loukianos, Kotsis, Vasileios, Athyros, Vasileios, Skalidis, Emmanouil, Kolovou, Genovefa, Garoufi, Anastasia, Bilianou, Eleni, Koutagiar, Iosif, Agapakis, Dimitrios, Kiouri, Estela, Antza, Christina, Katsiki, Niki, Zacharis, Evangelos, Attilakos, Achilleas, Sfikas, George, Anagnostis, Panagiotis, Panagiotakos, Demosthenes B., Liberopoulos, Evangelos N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257219/
https://www.ncbi.nlm.nih.gov/pubmed/32466791
http://dx.doi.org/10.1186/s12944-020-01289-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257219/
https://www.ncbi.nlm.nih.gov/pubmed/32466791
http://dx.doi.org/10.1186/s12944-020-01289-5

Ejemplares similares